Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy
High viral suppression rates were observed in those that returned to oral therapy after discontinuing LAI CAB/RPV. Individuals with substance use demonstrated a higher rate of LAI discontinuation, despite the potential benefit from LAIs in this population.
Authors
- Jeffrey Yin (ORCID: https://orcid.org/0000-0002-5125-8031)
- Kari Abulhosn
- Afsana Karim
- Laura P Bamford (ORCID: https://orcid.org/0000-0001-5988-8372)
- Lucas Hill (ORCID: https://orcid.org/0000-0002-5689-5865)
- Nimish Patel (ORCID: https://orcid.org/0000-0003-0921-549X)
- Tali Faggiano
Institutions
- University of San Diego (US)
- University of California San Diego (US)
- University of Montana (US)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-10-12
- DOI
- https://doi.org/10.1111/hiv.70128
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of California, San Diego